InVivo's latest enrollee brings INSPIRE study total to 15 patients — 4 notes

Spinal Tech

InVivo Therapeutics enrolled a new patient in its INSPIRE Study, testing the safety and efficacy of the Neuro-Spinal Scaffold for patients with complete thoracic AIS A spinal cord injury.

Here are four notes:

 

1. Portland-based Oregon Health & Science University enrolled the patient.

 

2. Jason J. Chang, MD, a neurological surgery assistant professor at Oregon Health & Science University, performed the surgery and implantation about 77 hours post-injury.

 

3. Dr. Chang serves as the site's co-study investigator.

 

4. This patient brings the study's total nationwide enrollment to 15 patients.

 

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Whitepapers